The paper is dedicated to the research output presented at the jubilee 50th edition of the international scientific conference Synthesis and Analysis of Drugs 2022 (SAL), which was organized and hosted by the Faculty of Pharmacy of Masaryk University in Brno. Since its launch in 1971, when Jozef Čižmárik from the Faculty of Pharmacy of the Comenius University in Bratislava started organizing SAL, significant progress in medicinal chemistry has been documented every year through the experimental works of researchers from different scientific institutions, both universities and academies of sciences as well as companies. We must point out long-term guest of SAL, Miroslav Protiva, co-founder of the antihistamine dosulepin and antiemetic moxastine-teoclas. As already mentioned, SAL 2022 was held at the Faculty of Pharmacy in Brno, which has been part of the University of Veterinary and Pharmaceutical Sciences for 25 years but became part of Masaryk University in 2021. Hence, the year 2022 was unique not only because of the 50th anniversary of this meeting but also for this year’s conference was the first within this institution. What topics were discussed among SAL conference participants? The meeting addressed all issues related to drug research—their design, preparation, analysis, and detection methods, as well as their biological activity studies, ADME studies, etc. The multidisciplinary character of the research, including topics on pharmaceutical technology and innovative dosage form investigation, was an additional value of the conference and its outcomes. We would like to thank the organization team and all participants for both high-quality research presentations resulting in the output of this paper and for the informal and friendly atmosphere.